Organic solvents in the pharmaceutical industry

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 1, 2010, Pages 3-12

  Grodowska, Katarzyna ^a,b   Parczewski, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b PLIVA Krakow Pharmaceutical Company   (Poland)

Author keywords

Acceptable limits; Organic solvents; Residual solvents

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONITRILE; ALCOHOL; ALIPHATIC HYDROCARBON; AMIDE; AMINE; AROMATIC HYDROCARBON; CYCLOHEXANE; ESTER DERIVATIVE; ETHER; HALIDE; HEXANE; IONIC LIQUID; KETONE; NITRILE; ORGANIC SOLVENT; PYRIDINE DERIVATIVE; SULFUR ACID DERIVATIVE; TOLUENE; WATER; XYLENE;

ANALYTIC METHOD; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG PACKAGING; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; GOVERNMENT REGULATION; INFRARED SPECTROSCOPY; LAW; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; REVIEW; SOLID PHASE MICROEXTRACTION; SUPERCRITICAL FLUID; THERMAL CONDUCTIVITY; THERMOGRAVIMETRY;

CHEMISTRY, PHARMACEUTICAL; CONSUMER PRODUCT SAFETY; DRUG CONTAMINATION; DRUG INDUSTRY; DRUG PACKAGING; GOVERNMENT REGULATION; GUIDELINES AS TOPIC; HUMANS; ORGANIC CHEMICALS; QUALITY CONTROL; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 76749150572     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. th Green Chemistry and Engineering Conference, Washington 2006.
2. ICH Q3C Guideline, Impurities: Residual solvents. http://www.emea.europa. eu/pdfs/human/ich/028395en.pdf.
3. XXXI USP, 〈467〉 General Chapter, Organic Volatile Impurities. Rockville MD 2007.
4. th Edition, 2.4.24. Identification and control of residual solvents. Strasbourg, 2006.
5. Enquête: Solvants rèsiduels. Pharmeuropa 2, 142 (1990).
6. Gachon M.: STP Pharma Pratiques 1, 531 (1991).
7. st edn., p. 977, ChemTec Publishing, Toronto, New York 2001.
8. Nojavan S., Ghassempour A., Bashour Y., Darbandi M.K., Ahmadi S.H.: J. Pharm. Biomed. Anal. 36, 983 (2005).
9. Al-Zoubi N., Kachrimanis K., Malmataris S.: Eur. J. Pharm. Sci. 17, 13 (2002).
10. nd edn., VCH Verlagsgesellschaft mbH, Weinheim 1988.
11. Acquah C., Karunanithi A. T., Achenie L. E. K.: Solvents for crystallization, paper presented at the 2006 Annual Meeting of American Institute of Chemical Engineers, San Francisco 2006.
12. nd edn., Churchill Livingstone, Oxford 2001.
13. Ahuja S.: Adv. Drug Deliv. Rev. 59, 3 (2007).
14. Barrio M-A., Hu J., Zhou P., Cauchon N.: J. Pharm. Biomed. Anal. 41, 738 (2006).
15. nd edn., p. 93, Marcel Dekker, New York 1990.
16. Stahl H.: Comparing different granulation techniques, http://www.niro.com/ndk-website/ niro/cmsdoc.nsf/WebDoc/ndkw67hhfv.
17. Herberger J., Murphy K., Munyakazi L., Cordia J., Westhaus E.: J. Control. Release 90, 181 (2003).
18. Zielhuis S.W., Nijsen J.F.W., Dorland L., Krijger G.C., A.D. van Het Ship, Hennink, W.E.: Int. J. Pharm. 315, 67 (2006).
19. Mollica J. A., Ahuja S., Cohen J.: J. Pharm. Sci. 67, 443 (1978).
20. Legrand S., Dugay J., Vial J.: J. Chromatogr. A. 999, 195 (2003).
21. Michulec M., Wardencki W.: Chromatographia 64, 191 (2006).
22. Osawa Z., Aiba M.: Polymer Photochem. 2, 339 (1982).
23. Avdovich H. W., Lebelle M. J., Savard C., Wilson W. L.: Forensic Sci. Int. 49, 225 (1991).
24. Thomasin C., Johansen P., Adler R., Bemsel R., Hottinger G., Altorfer H., Wright A. D., Wehrli H. P., Merkle B., Gander B.: Eur. J. Pharm. Biopharm. 42, 16 (1996).
25. st edn., Vol. 138, Marcel Dekker, New York 2004.
26. Kakumanu V., K., Bansal A., K.: Supercritical Fluid Technology in Pharmaceutical Research, http://www.touchbriefings.com/pdf/953/kakumanu-bansal. pdf.
27. st edn., Vol. 18, p. 219, Informa Healthcare, London 1998.
28. st edn., Vol. 92, p. 105, Kluwer, Dordrecht 2002.
29. http://www.who.int/intellectualproperty/studies/ Study5Annexes.pdf.